460 related articles for article (PubMed ID: 23361280)
41. [Centrosome hyperamplificationin oral precancerous lesions and squamous cell carcinomas].
Cai Y; Li BQ; Cheng QM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):238-41. PubMed ID: 15293475
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW
Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200
[TBL] [Abstract][Full Text] [Related]
43. Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.
Loro LL; Johannessen AC; Vintermyr OK
J Clin Pathol; 2005 Nov; 58(11):1157-62. PubMed ID: 16254104
[TBL] [Abstract][Full Text] [Related]
44. Increased nuclear β-catenin expression in oral potentially malignant lesions: A marker of epithelial dysplasia.
Reyes M; Rojas-Alcayaga G; Maturana A; Aitken JP; Rojas C; Ortega AV
Med Oral Patol Oral Cir Bucal; 2015 Sep; 20(5):e540-6. PubMed ID: 26241451
[TBL] [Abstract][Full Text] [Related]
45. MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Abidullah M; Nahar P; Ahmed SA; Kothari H; Vakeel S
J Int Soc Prev Community Dent; 2023; 13(2):124-132. PubMed ID: 37223448
[TBL] [Abstract][Full Text] [Related]
46. Analysis of immunohistochemical expression of k19 in oral epithelial dysplasia and oral squamous cell carcinoma using color deconvolution-image analysis method.
Safadi RA; Musleh AS; Al-Khateeb TH; Hamasha AA
Head Neck Pathol; 2010 Dec; 4(4):282-9. PubMed ID: 20882374
[TBL] [Abstract][Full Text] [Related]
47. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma.
Lin CY; Jeng YM; Chou HY; Hsu HC; Yuan RH; Chiang CP; Kuo MY
J Surg Oncol; 2008 May; 97(6):544-50. PubMed ID: 18297688
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
49. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
Cuevas-Nunez MC; Gomes CBF; Woo SB; Ramsey MR; Chen XL; Xu S; Xu T; Zhan Q; Murphy GF; Lian CG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):59-73.e2. PubMed ID: 28743666
[TBL] [Abstract][Full Text] [Related]
50. Suprabasal expression of Ki-67 antigen as a marker for the presence and severity of oral epithelial dysplasia.
Gonzalez-Moles MA; Ruiz-Avila I; Rodriguez-Archilla A; Martinez-Lara I
Head Neck; 2000 Oct; 22(7):658-61. PubMed ID: 11002319
[TBL] [Abstract][Full Text] [Related]
51. Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma.
Shahrabi-Farahani S; Gallottini M; Martins F; Li E; Mudge DR; Nakayama H; Hida K; Panigrahy D; D'Amore PA; Bielenberg DR
Am J Pathol; 2016 Apr; 186(4):1055-64. PubMed ID: 26877262
[TBL] [Abstract][Full Text] [Related]
52. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
[TBL] [Abstract][Full Text] [Related]
53. Presenilin 1/γ-secretase modulates P-cadherin processing and influences cell adhesion in oral squamous cell carcinoma cell lines.
Bauer K; Gosau M; Reinders J; Oefner P; Reichert TE; Bauer R
Carcinogenesis; 2013 Nov; 34(11):2622-8. PubMed ID: 23740836
[TBL] [Abstract][Full Text] [Related]
54. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
Li SX; Yu SF; Sun KH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis.
Sakamoto K; Aragaki T; Morita K; Kawachi H; Kayamori K; Nakanishi S; Omura K; Miki Y; Okada N; Katsube K; Takizawa T; Yamaguchi A
Histopathology; 2011 Mar; 58(4):531-42. PubMed ID: 21371075
[TBL] [Abstract][Full Text] [Related]
56. GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma.
Angadi VC; Angadi PV
J Oral Sci; 2015 Jun; 57(2):115-22. PubMed ID: 26062860
[TBL] [Abstract][Full Text] [Related]
57. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
58. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
59. Elastin remodeling: Does it play a role in priming the malignant phenotype of oral mucosa?
Prabhudesai SA; Carvalho K; Dhupar A; Spadigam A
Indian J Pathol Microbiol; 2023; 66(2):332-338. PubMed ID: 37077077
[TBL] [Abstract][Full Text] [Related]
60. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
